Facebook
Messenger
Twitter
LinkedIn
Email
Print
Mayo Researchers Explore Genetics Behind COVID-19 Outcomes
Share this:
Some patients with COVID-19 experience severe complications, such as organ damage, shortness of breath, neurological impairment and chronic fatigue. A team of researchers within Mayo Clinic Center for Individualized Medicine is contributing to the global effort of using advanced genetic sequencing to find out which genes influence disease outcomes.
“Our findings will be crucial in treating and caring for COVID-19 survivors, as well as to try to prevent lingering complications in newly infected people,” says Konstantinos Lazaridis, M.D., the Everett J. and Jane M. Hauck associate director of Mayo Clinic Center for Individualized Medicine.
Dr. Lazaridis and his team are building a library of genomic sequencing data of consented patients who tested positive for COVID-19. Learn more about Dr. Lazaridis' work at the Center for Individualized Medicine.
Make a gift now to help transform the future of health care today.
Eds Note: Through expertise, innovation and a commitment to its patient-first values, Mayo Clinic plays a leading role in the worldwide pandemic response. Watch Mayo [...]
From developing tests to detect the virus in a matter of months to testing patients for antibodies, Mayo Clinic Laboratories has been at [...]
To solve the challenges presented by COVID-19, it's important to look to the past. History shows that collaboration is the way forward when uncovering [...]